Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-26-055957
Filing Date
2026-05-06
Accepted
2026-05-06 09:39:04
Documents
7
Period of Report
2026-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2613738d1_6k.htm 6-K 10383
2 EXHIBIT 99.1 tm2613738d1_ex99-1.htm EX-99.1 231924
3 EXHIBIT 99.2 tm2613738d1_ex99-2.htm EX-99.2 66662
4 GRAPHIC tm2613738d1_ex99-1img001.jpg GRAPHIC 44637
5 GRAPHIC tm2613738d1_ex99-1img002.jpg GRAPHIC 1648
6 GRAPHIC tm2613738d1_ex99-2img001.jpg GRAPHIC 3067
7 GRAPHIC tm2613738d1_ex99-2img002.jpg GRAPHIC 1731
  Complete submission text file 0001104659-26-055957.txt   381139
Mailing Address ESSENER BOGEN 7 HAMBURG Germany 22419
Business Address ESSENER BOGEN 7 HAMBURG Germany 22419 49-40-560-810
Evotec SE (Filer) CIK: 0001412558 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34041 | Film No.: 26946278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)